What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Genetics
Apolipoprotein E, Alzheimer's disease, Internal medicine, Genetics and Disease are his primary areas of study.
His studies deal with areas such as Genetically modified mouse, Neuroscience, Central nervous system and Apolipoprotein B as well as Apolipoprotein E.
His Apolipoprotein B research incorporates elements of Cardiology, Cognition, Allele and Cognitive decline.
His Alzheimer's disease research incorporates themes from Plasma protein binding, Dementia and Degenerative disease.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Membrane protein.
Allen D. Roses interconnects Genotyping, Genotype, Gerontology and Clinical trial in the investigation of issues within Disease.
His most cited work include:
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. (3560 citations)
- Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase (1285 citations)
- Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease (1165 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Apolipoprotein E, Genetics, Disease, Internal medicine and Alzheimer's disease.
His Apolipoprotein E research is multidisciplinary, incorporating perspectives in Bioinformatics, Allele, Genotype and Age of onset.
Allen D. Roses combines subjects such as Cognition, Genetic association and Risk factor with his study of Allele.
As part of the same scientific family, he usually focuses on Disease, concentrating on Clinical trial and intersecting with Pharmacogenetics.
His Internal medicine research is multidisciplinary, relying on both Endocrinology, Oncology and Cardiology.
His studies in Alzheimer's disease integrate themes in fields like Apolipoprotein B, Immunology, Dementia, Neuroscience and Degenerative disease.
He most often published in these fields:
- Apolipoprotein E (43.60%)
- Genetics (36.05%)
- Disease (29.94%)
What were the highlights of his more recent work (between 2010-2020)?
- Apolipoprotein E (43.60%)
- Disease (29.94%)
- Genetics (36.05%)
In recent papers he was focusing on the following fields of study:
Allen D. Roses spends much of his time researching Apolipoprotein E, Disease, Genetics, Alzheimer's disease and Internal medicine.
Allen D. Roses has included themes like Dementia, Genotype, Allele, Haplotype and Age of onset in his Apolipoprotein E study.
Allen D. Roses is studying Allele frequency, which is a component of Allele.
His Disease study combines topics in areas such as Biomarker and Clinical trial, Bioinformatics.
Allen D. Roses has researched Alzheimer's disease in several fields, including Neurology, Cohort study, Gerontology and Physiology.
The various areas that Allen D. Roses examines in his Internal medicine study include Diabetes mellitus, Endocrinology, Cognition and Oncology.
Between 2010 and 2020, his most popular works were:
- The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ɛ3/ɛ3 genotype (91 citations)
- CAP—advancing the evaluation of preclinical Alzheimer disease treatments (65 citations)
- Using genetics to enable studies on the prevention of Alzheimer's disease. (59 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
His primary areas of study are Apolipoprotein E, Alzheimer's disease, Genetics, Genotype and Disease.
The Apolipoprotein E study combines topics in areas such as Allele and Physiology.
His work carried out in the field of Alzheimer's disease brings together such families of science as Guideline adherence, Gerontology and Allele frequency.
The study of Genetics is intertwined with the study of Neuroscience in a number of ways.
His research in Genotype intersects with topics in Endocrinology, Internal medicine and Age of onset.
In his study, which falls under the umbrella issue of Disease, Prospective cohort study, Phenotype, Pharmacology and Pioglitazone is strongly linked to Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
